Inhibrx Biosciences, Inc. · NASDAQ:INBX

Lappe Mark bought 10,040 Inhibrx Biosciences, Inc. shares (Form 4)

Traded Oct 14, 2026 · Filed Oct 14, 2026

On Oct 14, 2026, Lappe Mark (Director, Chief Executive Officer) bought 10,040 Inhibrx Biosciences, Inc. shares at an average US$84.56 for US$849K, leaving 170,000 shares. Filed Oct 14, 2026 (Form 4).

Bought: 10,040 shares
Price: US$84.56 average (US$84.07 to US$85.76)
Value: US$849K
Holding after: 170,000 shares (held indirectly)
Trading plan: No
Role: Director, Chief Executive Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 14, 2026	Common Stock	Buy	2,470	US$84.07	743,018	Indirect
Oct 14, 2026	Common Stock	Buy	2,470	US$85.00	745,488	Indirect
Oct 14, 2026	Common Stock	Buy	100	US$85.76	745,588	Indirect
Oct 14, 2026	Common Stock	Buy	2,449	US$84.07	167,449	Indirect
Oct 14, 2026	Common Stock	Buy	2,451	US$85.00	169,900	Indirect
Oct 14, 2026	Common Stock	Buy	100	US$85.76	170,000	Indirect

Source

Download original · View original at SEC

Related